skinny.

Latest / The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified

403. Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences (Risa Stack)

Risa Stack of The Production Board joins Nate to discuss Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences. In this episode we cover:

Entrepreneurship, Venture Capital, and Starting Companies

Venture Studio Model, Technical Risk, and Investing in Businesses

Challenges in Therapeutic Development and Commercialization

Prioritizing People Over Products, and Assessing the Funding Environment for Critical Industries

Biotech, Life Extension, and Investment Strategies

Gene Editing and Cell Therapy Technologies

Personalized Medicine

Guest Links:

LinkedIn…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.